Proceed to Pancreaticoduodenectomy After Optimization
Patient Selection and Performance Status
Renal Function Requirements
Biliary Stenting Considerations
Timing of Surgery After Drainage
Restaging Imaging Prior to Resection
Surgical Technique and Extent of Resection
Age‑Related Considerations
Avoiding Unnecessary Delays
Treatment of Pancreatic Head Cancer in Elderly Female Patients
Introduction to Treatment
- For an elderly female patient with pancreatic head cancer, radical surgery (partial pancreaticoduodenectomy/Whipple procedure) followed by 6 months of adjuvant chemotherapy (gemcitabine or 5-FU) is the best option if the tumor is resectable and the patient has acceptable comorbidity status, as this is the only curative approach with 5-year survival rates of approximately 20% 5, 6, 7
Determining Surgical Candidacy
- Elderly patients do benefit from radical surgery, but comorbidity becomes the critical limiting factor, especially in patients older than 75-80 years 5, 6, 7
Surgical Approach
- The goal is R0 resection (complete microscopic tumor clearance) 6, 7
- Standard lymphadenectomy should include nodes of the hepatoduodenal ligament, common hepatic artery, portal vein, right-sided celiac artery, and right half of superior mesenteric artery 5, 6
- Extended lymphadenectomy provides no additional benefit 5, 6
Resectability Assessment
- Resectable: Tumor localized to pancreas without major vessel involvement 5, 6
- Unresectable: Tumor involves celiac axis or superior mesenteric artery (T4 disease) 6, 7
Adjuvant Therapy
- All patients who undergo resection should receive 6 months of adjuvant chemotherapy with either gemcitabine or 5-FU 5, 8
- Adjuvant chemotherapy improves 5-year survival from approximately 9% to 20% 9
- Patients benefit from adjuvant chemotherapy even after R1 resection (positive margins) 5, 9
Management of Unresectable Disease
- Chemotherapy with gemcitabine is the standard palliative approach 8
- For borderline resectable tumors, neoadjuvant chemotherapy (gemcitabine plus nab-paclitaxel) may achieve downsizing and conversion to resectable status 5
- Endoscopic biliary stenting with metal stents is preferred for jaundice relief in patients with life expectancy >3 months 8